Komori
Lihit Lab. (7975) · RiskMitigated

Excess Inventory Risk Associated with Long Lead Times for Overseas Procurement

First written in FY2018. 7 of 9 entries say "Mitigated", first in FY2020. Latest entry: FY2027-H1.

9entries
9years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2018MitigatedFY2020 – FY2025-H1MitigatedFY2026-H1 – FY2027-H12018: 120182019: 020192020: 120202021: 020212022: 020222023: 020232024: 220242025: 220252026: 32026
Same theme, other companies
Inventory buildup due to longer procurement lead timesA theme 2 companies write about · 2 as a headwind · 0 as a tailwind

0 other companies' latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2027-H1MitigatedAnnual report

    「Funds generated by operating activities amounted to ¥904 million. This was mainly due to decreases in trade receivables and inventories, as well as depreciation and amortization.」

    The decrease in inventories was a main factor behind the ¥904 million in cash flow from operating activities, with the reduction of inventories that increased in the previous fiscal year continuing.
  2. 2026-10-02MitigatedEarnings

    「これは主として、売上債権、棚卸資産の減少、減価償却費等によるものであります。」

    棚卸資産の減少が営業活動によるキャッシュ・フロー904百万円の増加要因として記載され、在庫圧縮が示されている。
  3. FY2026MitigatedAnnual report

    「Cash provided by operating activities increased by ¥47 million, mainly due to depreciation and amortization, a decrease in inventories and other factors.」

    The decrease in inventories was a factor behind the increase in cash flow from operating activities, with the inventory reduction following the increase in the previous fiscal year described.
  4. FY2026-H1MitigatedAnnual report

    「Cash provided by operating activities increased by ¥544 million, mainly due to decreases in inventories and trade receivables, as well as depreciation and amortization.」

    The decrease in inventories was a factor behind the increase in cash flow from operating activities, indicating a reduction in excess inventory through inventory management.
  5. FY2025Increase in inventoriesAnnual report

    「Merchandise and products 1,884,165 2,104,210 Raw materials and supplies 573,846 669,808」

    Merchandise and products, and raw materials and supplies, increased from the end of the previous fiscal year, representing a change from the previous trend of inventory reductions.
  6. FY2025-H1MitigatedAnnual report

    「Cash provided by operating activities increased by ¥606 million, mainly due to decreases in inventories and trade receivables, as well as depreciation and amortization.」

    The decrease in inventories was a factor behind the increase in cash flow from operating activities, indicating a reduction in excess inventory through inventory management.
  7. FY2024MitigatedAnnual report

    「Cash provided by operating activities increased by ¥663 million, mainly due to a decrease in inventories and depreciation and amortization.」

    The decrease in inventories is cited as a factor behind the increase in operating cash flow, indicating the status of measures to address the risk of excess inventory.
  8. FY2020MitigatedAnnual report

    「Among current assets, inventories of merchandise, products, raw materials and other items decreased as a result of thorough inventory management, while cash and deposits increased.」

    The Company states that inventories declined as a result of thorough inventory management, indicating measures to address the risk of excess inventory associated with expanded overseas procurement.
  9. FY2018First statedAnnual report

    「In addition, as overseas procurement expands, inventory levels must be increased to ensure stable supply in response to longer lead times. However, changes in market conditions may result in excess inventory and inventory valuation issues, potentially affecting the Group's operating results and financial condition.」

    The Company indicates that increased inventories associated with expanded overseas procurement may lead to excess inventory and inventory valuation issues.
Moved together

"Expanding the product lineup for personal use and launching new products" moved the same way as this thread, in the same document, in 6 of its 9 moves.

654443★123456
  1. ★This thread
  2. 1Expanding the product lineup for personal use and launching new products6×
  3. 2Sales Growth in the Binders and Clear Books Division5×
  4. 3Higher Procurement Costs and Foreign Exchange Losses Due to Exchange-Rate Fluctuations4×
  5. 4High Equity Ratio and Committed Credit Lines4×
  6. 5Strengthening the development of sales channels, adjacent markets and overseas markets4×
  7. 6Procurement Cost Stabilization and Expense Control3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Lihit Lab. yet. It last moved in the Earnings of 2026-10-02: "Mitigated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Excess Inventory Risk Associated with Long Lead Times for Overseas Procurement | LIHIT LAB.,INC. (7975) | Komori